Gain-of-function Nav1.8 mutations in painful neuropathy

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-10-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1073/pnas.1216080109PMID 23115331PMCID PMC3511073
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathy‐associated NaV1.7 variant I228M impairs integrity of dorsal root ganglion neuron axons

  2013cited by this paper
• Genetic aspects of sodium channelopathy in small fiber neuropathy

  2012cited by this paper
• Nav1.7-related small fiber neuropathy

  2012cited by this paper
• Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy

  2012cited by this paper
• Small-fibre neuropathies—advances in diagnosis, pathophysiology and management

  2012cited by this paper
• Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system

  2012cited by this paper
• Sodium-calcium exchanger and multiple sodium channel isoforms in intra-epidermal nerve terminals

  2010cited by this paper
• European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Fe‐deration of Neurological Societies and the Peripheral Nerve Society

  2010cited by this paper
• Sodium channels in normal and pathological pain.

  2010cited by this paper
• Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

  2010cited by this paper
• Intraepidermal nerve fiber density and its application in sarcoidosis

  2009cited by this paper
• Transfection of rat or mouse neurons by biolistics or electroporation

  2009cited by this paper
• Voltage-clamp and current-clamp recordings from mammalian DRG neurons

  2009cited by this paper
• A novel Nav1.7 mutation producing carbamazepine‐responsive erythromelalgia

  2009cited by this paper
• NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

  2008cited by this paper
• The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain

  2008cited by this paper
• Voltage‐gated sodium channel expression in rat and human epidermal keratinocytes: Evidence for a role in pain

  2008cited by this paper
• Orthodromic spike generation from electrical stimuli in the rat carotid body: implications for the afferent spike generation process

  2007cited by this paper
• Sensory neuron sodium channel Nav1.8 is essential for pain at low temperatures

  2007cited by this paper
• Neurobiology: A channel sets the gain on pain

  2006cited by this paper
• A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.

  2006cited by this paper
• A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons.

  2006cited by this paper
• Mutations of Neuronal Voltage‐gated Na+ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB)

  2004cited by this paper
• The TTX‐Resistant Sodium Channel Nav1.8 (SNS/PN3): Expression and Correlation with Membrane Properties in Rat Nociceptive Primary Afferent Neurons

  2003cited by this paper
• Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels.

  2003cited by this paper
• Roles of Tetrodotoxin (TTX)-Sensitive Na+ Current, TTX-Resistant Na+ Current, and Ca2+ Current in the Action Potentials of Nociceptive Sensory Neurons

  2002cited by this paper
• Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus.

  2001cited by this paper
• Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons.

  2001cited by this paper
• The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways

  1999cited by this paper
• Slow Closed-State Inactivation: A Novel Mechanism Underlying Ramp Currents in Cells Expressing the hNE/PN1 Sodium Channel

  1998cited by this paper
• Preparation of Genomic DNA from Mammalian Tissue

  1998cited by this paper
• Downregulation of Tetrodotoxin-Resistant Sodium Currents and Upregulation of a Rapidly Repriming Tetrodotoxin-Sensitive Sodium Current in Small Spinal Sensory Neurons after Nerve Injury

  1997cited by this paper
• A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons

  1996cited by this paper
• Mechanisms of Injury‐Induced Calcium Entry into Peripheral Nerve Myelinated Axons: Role of Reverse Sodium‐Calcium Exchange

  1996cited by this paper
• Structure and Function of a Novel Voltage-gated, Tetrodotoxin-resistant Sodium Channel Specific to Sensory Neurons (*)

  1996cited by this paper
• Thermal testing: normative data and repeatability for various test algorithms.

  1994cited by this paper
• Preparation of Genomic DNA from Mammalian Tissue

  1993cited by this paper
• Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger

  1992cited by this paper
• Low density of sodium channels supports action potential conduction in axons of neonatal rat optic nerve.

  1989cited by this paper

• Tenascin C+ myofibroblasts exacerbate vascular neointimal hyperplasia by propagation of nerve-macrophage interactions in mice

  2026cites this paper
• Clinical Neurophysiology

  2026cites this paper
• Shaping the Action Potential in Dorsal Root and Trigeminal Ganglia Neurons: Relevance to Pain Mechanisms

  2026cites this paper
• Targeting Nav Channels for Pain Relief: Structural Insights and Therapeutic Opportunities

  2026cites this paper
• The intrinsic reason why complementary tests (clinical neurophysiology, neuroimaging, skin biopsy) cannot establish the diagnosis of neuropathic pain

  2026cites this paper
• Suzetrigine, a NaV1.8 Inhibitor as a Novel Approach for Pain Therapy—A Medicinal and Chemical Drug Profile

  2026influential citation
• The parabss1 Drosophila melanogaster as Model for Chronic Nociception: Insights Into Cannabidiol Analgesic Effects

  2026influential citation
• A Case Report of Familial Episodic Pain Syndrome Type 3 in a 5-Year-Old Boy

  2026cites this paper
• From neuroimmune circuits to targeted therapy of chronic pruritus

  2026cites this paper
• Suzetrigine: A New, Non-Opioid, Acute Pain Management Agent for Podiatric Physicians.

  2025cites this paper
• Mitochondrial activity tunes nociceptor resilience to excitotoxicity.

  2025cites this paper
• Sodium channel modulation as a therapeutic strategy for chemotherapy-induced peripheral neurotoxicity

  2025influential citation
• Actualización en el manejo del dolor: ¿Qué nuevas herramientas tenemos disponibles?

  2025cites this paper
• Contusive spinal cord injury causes Nav1.8 dysfunction to upregulate small sensory neuron excitability

  2025cites this paper
• Neuronal physiology of amygdala neurons in the context of injury and pain

  2025cites this paper
• Voltage-gated sodium channels in excitable cells as drug targets

  2025cites this paper
• Etiological basis for chronic pain genetic variation in brain and dorsal root ganglia cell types

  2025cites this paper
• Conformational restriction enables discovering a series of chroman derivatives as potent and selective NaV1.8 inhibitors with improved pharmacokinetic properties.

  2025cites this paper
• A hydrophobic loop of the spider-venom peptide Tl1a drives activity at NaV1.8.

  2025cites this paper
• Glycyrrhiza uralensis Fisch: A novel source of analgesic activity through NaV1.8 sodium channel modulation.

  2025cites this paper
• Suzetrigine, a selective NaV1.8 inhibitor in acute and chronic pain: mechanistic insights, clinical outcomes, and future perspectives.

  2025cites this paper
• Reduced functional resting-state connectivity in chronic pain patients with small fiber neuropathy.

  2025cites this paper
• Temporal refinement of Dach1 expression contributes to the development of somatosensory neurons

  2025cites this paper
• Targeting sodium channels — challenges for acute pain and the leap to chronic pain

  2025cites this paper
• A novel Nav1.7, Nav1.8, and Nav1.9 blocker, ANP-230, has broad analgesic efficacy in preclinical pain models with favorable safety margins.

  2025cites this paper
• Humanized NaV1.8 rats overcome cross-species potency shifts in developing novel NaV1.8 inhibitors

  2025cites this paper
• Voltage-gated sodium channels (NaV) in GtoPdb v.2025.3

  2025cites this paper
• Phentolamine selectively blocks C-fiber conduction in different species, including humans

  2025influential citation
• Small Fiber Neuropathy in Sarcoidosis

  2025cites this paper
• Nav1.8 and Chronic Pain: From Laboratory Animals to Clinical Patients

  2025cites this paper
• Sodium channels as a new target for pain treatment

  2025cites this paper
• Advances in the discovery of selective NaV1.8 inhibitors for pain management.

  2025cites this paper
• The cell-type–specific genetic architecture of chronic pain in brain and dorsal root ganglia

  2025cites this paper
• Nav1.8, an analgesic target for nonpsychotomimetic phytocannabinoids

  2025cites this paper
• The Recent Research Progress on the Novel Drug NaV1.8 Selective Inhibitor Suzutrigine for Pain Treatment

  2025cites this paper
• Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain

  2025cites this paper
• Nav1.8: Intrinsic limits on the functional effect of abrogation in DRG neurons.

  2025cites this paper
• Human sensory neurons exhibit cell-type-specific, pain-associated differences in intrinsic excitability and expression of SCN9A and SCN10A

  2025cites this paper
• Voltage-Gated Ion Channels in Neuropathic Pain Signaling

  2025influential citation
• The peripheral Atf3 + neuronal population is responsible for nerve regeneration at the early stage of nerve injury revealed by single-cell RNA sequencing

  2024cites this paper
• Human pain channelopathies.

  2024cites this paper
• Painful stimulation increases functional connectivity between supplementary motor area and thalamus in patients with small fibre neuropathy

  2024cites this paper
• The temporal refinement of Dach1 is a key step in the functional maturation of primary somatosensory neurons

  2024cites this paper
• Analgesia and peripheral c-fiber modulation by selective Nav1.8 inhibition in rhesus

  2024cites this paper
• Inhibition of TTX-S Na+ currents by a novel blocker QLS-278 for antinociception.

  2024cites this paper
• 2-Aminopyridines as Potent and Selective Nav1.8 Inhibitors Exhibiting Efficacy in a Nonhuman Primate Pain Model.

  2024cites this paper
• Insights into the voltage-gated sodium channel, NaV1.8, and its role in visceral pain perception

  2024cites this paper
• Interplay of Nav1.8 and Nav1.7 channels drives neuronal hyperexcitability in neuropathic pain

  2024cites this paper
• Genetic Analysis of SCN11A, SCN10A, and SCN9A in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria

  2024cites this paper
• Cutaneous nerve biopsy in patients with symptoms of small fiber neuropathy: a retrospective study

  2024cites this paper
• Nav1.8 in small dorsal root ganglion neurons contributes to vincristine-induced mechanical allodynia.

  2024cites this paper
• Compartment-specific regulation of NaV1.7 in sensory neurons after acute exposure to TNF-α

  2024influential citation
• How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a functional assessment

  2024cites this paper
• Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action

  2024cites this paper
• Reduced gray matter volume and cortical thickness in patients with Small-Fiber Neuropathy.

  2024cites this paper
• Computational modeling to study the impact of changes in Nav1.8 sodium channel on neuropathic pain

  2024cites this paper
• A review of dorsal root ganglia and primary sensory neuron plasticity mediating inflammatory and chronic neuropathic pain

  2024cites this paper
• Frontiers in Acute Pain Management: Emerging Concepts in Pain Pathways and the Role of VX-548 as a Novel NaV1.8 Inhibitor: A Narrative Review

  2024cites this paper
• Small fiber neuropathy.

  2024cites this paper
• The role of the ubiquitin system in the onset and reversal of neuropathic pain.

  2024cites this paper
• T cell death-associated gene 8-mediated distinct signaling pathways modulate the early and late phases of neuropathic pain

  2024cites this paper
• Structural basis of inhibition of human NaV1.8 by the tarantula venom peptide Protoxin-I

  2024cites this paper
• VX-548 in the treatment of acute pain.

  2024cites this paper
• Development and characterization of pyridyl carboxamides as potent and highly selective Nav1.8 inhibitors.

  2024cites this paper
• Molecular mechanisms of neuropathic pain.

  2024cites this paper
• The Evolving Landscape of Small Fiber Neuropathy

  2024influential citation
• Small Fiber Neuropathy in Burning Mouth Syndrome: A Systematic Review

  2024cites this paper
• Clinical pain management: Current practice and recent innovations in research

  2024cites this paper
• Unique electrophysiological property of a novel Nav1.7, Nav1.8, and Nav1.9 sodium channel blocker, ANP-230.

  2024cites this paper
• Discovery of E0199: A novel compound targeting both peripheral NaV and KV7 channels to alleviate neuropathic pain

  2024cites this paper
• Pain's puzzle pieces: MAGI-1, NaV1.8, degradation, analgesia

  2024cites this paper
• Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications

  2023cites this paper
• Chemogenetic Silencing of NaV1.8-Positive Sensory Neurons Reverses Chronic Neuropathic and Bone Cancer Pain in FLEx PSAM4-GlyR Mice

  2023cites this paper
• Peripheral mechanisms of peripheral neuropathic pain

  2023cites this paper
• Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.

  2023cites this paper
• Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders

  2023cites this paper
• How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a comparison of two protocols

  2023cites this paper
• Peripheral temperature dysregulation associated with functionally altered NaV1.8 channels

  2023cites this paper
• Voltage-gated sodium channels (NaV) in GtoPdb v.2023.1

  2023cites this paper
• Targeting a Peripheral Sodium Channel to Treat Pain.

  2023cites this paper
• Genetic Profiling of Sodium Channels in Diabetic Painful and Painless and Idiopathic Painful and Painless Neuropathies

  2023cites this paper
• In vitro characterization of cells derived from a patient with the GLA variant c.376A>G (p.S126G) highlights a non-pathogenic role in Fabry disease

  2023influential citation
• Ectopic expression of Nav1.7 in spinal dorsal horn neurons induced by NGF contributes to neuropathic pain in a mouse spinal cord injury model

  2023cites this paper
• Investigating genotype–phenotype relationship of extreme neuropathic pain disorders in a UK national cohort

  2023cites this paper
• Tenascin C+ papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis

  2023cites this paper
• Paclitaxel effects on axonal localization and vesicular trafficking of NaV1.8

  2023cites this paper
• TRPA1 rare variants in chronic neuropathic and nociplastic pain patients

  2023cites this paper
• Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors

  2023cites this paper
• Peptide toxins that target vertebrate voltage-gated sodium channels underly the painful stings of harvester ants

  2023cites this paper
• Peripheral Ion Channel Genes Screening in Painful Small Fiber Neuropathy

  2022cites this paper
• Expanding the genetic causes of small‐fiber neuropathy: SCN genes and beyond

  2022influential citation
• Biallelic Loss of Function Mutation in Sodium Channel Gene SCN10A in an Autism Spectrum Disorder Trio from Pakistan

  2022cites this paper
• Nav1.7 and Nav1.8 form supramolecular active clusters with TRKB in mouse and human DRG neurons during development of neuropathic pain

  2022cites this paper
• Targeting the tamoxifen receptor within sodium channels to block osteoarthritic pain.

  2022cites this paper
• Familial Episodic Pain Syndromes

  2022cites this paper
• Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain

  2022cites this paper
• Derivation of nociceptive sensory neurons from hiPSCs with early patterning and temporally controlled NEUROG2 overexpression

  2022cites this paper
• Structural basis for high-voltage activation and subtype-specific inhibition of human Nav1.8

  2022cites this paper
• Genetic pain loss disorders

  2022cites this paper
• Atrial fibrillation with debut in childhood, probably associated with variant D1907H in the SCN10a gene

  2022cites this paper